[Second Reprint]

ASSEMBLY, No. 1073

STATE OF NEW JERSEY

219th LEGISLATURE

 

PRE-FILED FOR INTRODUCTION IN THE 2020 SESSION

 


 

Sponsored by:

Assemblywoman  SHANIQUE SPEIGHT

District 29 (Essex)

Assemblywoman  ELIANA PINTOR MARIN

District 29 (Essex)

Assemblywoman  ANGELA V. MCKNIGHT

District 31 (Hudson)

Assemblywoman  BRITNEE N. TIMBERLAKE

District 34 (Essex and Passaic)

 

Co-Sponsored by:

Assemblywomen Reynolds-Jackson, Jasey, Assemblyman Mukherji, Assemblywomen Jimenez, Tucker, Vainieri Huttle and Downey

 

 

 

 

SYNOPSIS

     Establishes requirements to screen certain people who are pregnant and who have given birth for preeclampsia.

 

CURRENT VERSION OF TEXT

     As reported by the Senate Health, Human Services and Senior Citizens Committee on June 10, 2021, with amendments.

  


An Act concerning preeclampsia 2[testing for pregnant women] screenings2 and supplementing Title 26 of the Revised Statutes.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    a.  The Commissioner of Health shall require every hospital 1[that provides inpatient maternity services]1 in the State, every birthing center licensed in the State pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.), 1every federally qualified health center, and [or]1 every physician or health care practitioner in the State providing care to a pregnant 2[woman] person2 or a 2[woman] person2 who has given birth 2,2 to 1[administer to the woman a test] screen the 2[woman1] person2 for preeclampsia 2[, if the woman] if the person2 shows symptoms of the condition.  1[The test shall include, but not be limited to, blood tests, ultrasonography, and non-stress tests that monitor a baby’s health] Screening tools shall be based on industry best practices and guidance, as determined by the American College of Obstetricians and Gynecologists, the 2[American Academy of Family Physicians] Preeclampsia Foundation2 , or 2[other nationally recognized] another nationally-recognized2 body 2[, as determined] as may be designated2 by the commissioner1 .

     b.    A hospital that provides inpatient maternity services 1[or], a1 licensed birthing center 1, or a federally qualified health center1 providing care to, or a physician or other health care practitioner who is the primary caregiver for, a pregnant 2[woman] person2 or a 2[woman] person2 who seeks treatment within 2[four] six2 weeks of giving birth, shall, in accordance with guidelines developed by the commissioner:

     (1)   provide the 2[woman] person2 with information on preeclampsia 1and potential warning signs and symptoms1;

     (2)   inform the 2[woman] person2 of the benefits of being 1[tested] screened1 for preeclampsia if 2[she] the person2 shows symptoms of the condition, and that 2[she] the person2 is required to be 1[tested] screened1 for preeclampsia unless 2[she] the person2 2[indicates in writing her] issues a written2 refusal to be 1[tested] screened1 2, which refusal shall be provided2 on a form and in a manner prescribed by the commissioner 2consistent with the provisions of subsection c. of this section2 ; 2[and]2

     (3)   1[test] screen1 the 2[woman] person2 for preeclampsia unless 2[she indicates her] the person provides2 written refusal as 2[hereinabove]2 provided 2in paragraph (2) of this subsection2 .  The 2[woman] person2 shall, on the 2[same]2 form and in a manner prescribed by the commissioner 2consistent with subsection c. of this section2 , acknowledge receipt of the information provided by the hospital, birthing center, 2federally qualified health center,2 physician, or health care practitioner, as applicable, regarding the benefits of being 1[tested] screened1 for preeclampsia 2; and

     (4)   encourage the person to routinely engage in home blood pressure monitoring2 .

     c.     2The commissioner shall develop a standardized form to be used for the purposes of providing the acknowledgement required pursuant to paragraph (3) of subsection b. of this section, which may also be used to provide written refusal to undergo a screening for preeclampsia pursuant to paragraph (2) of subsection b. of this section, if applicable.

     d.2  Upon receipt of the results of 1[the test] any screening1 conducted pursuant to subsection a. of this section, the hospital 2[that provides inpatient maternity services]2 , licensed birthing center, 1federally qualified health 2[care centers] center2 ,1 or physician or health care practitioner 2, as applicable,2 shall discuss the results with 2[a pregnant women or women who has given birth] the person2 and, if the 2[woman] person has a positive screening2 1[tests positive] 2[screens1]2 for preeclampsia, develop a treatment plan to minimize the 2[woman’s] person’s2 risk from preeclampsia.

 

     2.    The Commissioner of Health, pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt rules and regulations to effectuate the purposes of this act.

 

     3.    This act shall take effect immediately.